Amgen Increases Bid for Onyx Pharmaceuticals


Aug 07, 2013


Amgen Inc. boosted its offer for Onyx Pharmaceuticals to $130 a share, according to an unnamed source familiar with the matter. Onyx said in June that it was working with advisers to find a buyer after spurning an offer of $120 a share from Thousand Oaks, California-based Amgen. Read the full story
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments